Our Impact
Project HOPE works closely with Egypt’s Ministry of Health and Population, as well as local health workers, to strengthen local health systems, educate health workers, and improve care for people living with NCDs.
Building Health Systems
Project HOPE has reached thousands of health care workers through our work developing the National Training Institute in Cairo, we have reached thousands of health workers with specialty trainings in emergency medicine, trauma, infection control, family medicine, HIV/AIDS care and treatment, and diabetes care and treatment.
Treating Rare Diseases
Gaucher disease, a rare genetic disorder, causes the buildup of fatty cells in the liver, spleen, bone marrow, and nervous system. The disease occurs in up to 1.5 in 100,000 births in the general population and affects more people in Egypt than any other country worldwide.
Since 1999, Project HOPE and Sanofi Genzyme’s Gaucher Initiative has contributed to substantial treatment improvements. We’ve trained more than 500 health workers, enrolled more than 300 patients, and are supporting ongoing treatment for 136 patients at seven university children’s hospitals across the country. This program provides essential, lifesaving medicines, educational resources, and support for families affected by Gaucher’s disease.
Reducing Noncommunicable Diseases
Noncommunicable diseases (NCDs) are the leading cause of death in Egypt, with cancer, diabetes, cardiovascular diseases, and other NCDs accounting for 82% of deaths. Tobacco use, alcohol abuse, unhealthy diet, and lack of physical activity are four key factors contributing to the rise in NCD threats. 23% of adults in Egypt smoke and 1 in every 3 people live with obesity. Project HOPE trains and equips health workers in health facilities, university hospitals, and the Ministry of Health and Population with the tools they need to prevent, treat, and manage NCDs.
Source link : https://www.projecthope.org/region/middle-east-north-africa/egypt/
Author :
Publish date : 2024-05-16 06:21:51
Copyright for syndicated content belongs to the linked Source.
